The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,183,043 in first-year total cost, median $333,918.
Most frequent study sections
- Special Emphasis Panel[ZAI1 KGH-I (J1)]3
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- OKLAHOMA MEDICAL RESEARCH FOUNDATION1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success2UM1AI144292-06 | JAMES, JUDITH A | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | $767,250 | ZAI1 |
| 2024 | Targeting T cell Subsets in Autoimmune Disease2UM1AI144295-06 | STONE, JOHN H | MASSACHUSETTS GENERAL HOSPITAL, MA | $333,918 | ZAI1 |
| 2024 | Johns Hopkins Autoimmunity Center of Excellence1UM1AI181725-01 | PAIK, JULIE JISUN | JOHNS HOPKINS UNIVERSITY, MD | $81,875 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.